Cognitive, emotional, and behavioral mediators of the impact of coping self-efficacy on adaptation to breast cancer: An international prospective study.


Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
09 2021
Historique:
revised: 14 04 2021
received: 06 03 2021
accepted: 10 05 2021
pubmed: 18 5 2021
medline: 25 2 2023
entrez: 17 5 2021
Statut: ppublish

Résumé

The main objective of this prospective multicenter study was to examine whether illness representations of control, affect, and coping behaviors mediate the effects of self-efficacy to cope with cancer on psychological symptoms and overall quality of life, in breast cancer patients. Data from 413 women (Mean age = 54.87; SD = 8.01), coming from four countries (i.e., Finland, Israel, Italy, Portugal), who received medical therapy for their early breast cancer, were analyzed. Coping self-efficacy was assessed at baseline. Potential mediators were assessed three months later, and outcomes after six months. Coping self-efficacy was related to all mediators and outcomes. Illness representations of treatment control, positive and negative affect, and certain coping behaviors (mostly, anxiety preoccupation) mediated the effects of coping self-efficacy. Coping self-efficacy was related to each outcome through a different combination of mediators. Coping self-efficacy is a major self-regulation factor which is linked to well-being through multiple cognitive, emotional, and behavioral pathways. Enhancement of coping self-efficacy should be a central intervention goal for patients with breast cancer, towards promotion of their well-being.

Identifiants

pubmed: 33998100
doi: 10.1002/pon.5730
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1555-1562

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Fatiregun OA, Olagunju AT, Erinfolami AR, Fatiregun OA, Arogunmati OA, Adeyemi JD. Anxiety disorders in breast cancer: prevalence, types, and determinants. J Psychosoc Oncol. 2016;34(5):432-447. https://doi.org/10.1080/07347332.2016.1196805
Mansano-Schlosser TC, Ceolim MF, Valerio TD. Poor sleep quality, depression and hope before breast cancer surgery. Appl Nurs Res. 2017;34:7-11. https://doi.org/10.1016/j.apnr.2016.11.010
Foster C, Wright D, Hill H, Hopkinson J, Roffe L. Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eur J Cancer Care. 2009;18(3):223-247. https://doi.org/10.1111/j.1365-2354.2008.01001.x
Bandura A. Self-Efficacy: The Exercise of Control. New York, NY: Freeman & Co; 1997.
Banik A, Schwarzer R, Knoll N, Czekierda K, Luszczynska A. Self-efficacy and quality of life among people with cardiovascular diseases: a meta-analysis. Rehabil Psychol. 2018;63(2):295-312. https://doi.org/10.1037/rep0000199
Knowles SR, Apputhurai P, O'Brien CL, Ski CF, Thompson DR, Castle DJ. Exploring the relationships between illness perceptions, self-efficacy, coping strategies, psychological distress and quality of life in a cohort of adults with diabetes mellitus. Psychol Health & Med. 2020;25(2):214-228. https://doi.org/10.1080/13548506.2019.1695865
Park CL, Gaffey AE. Relationships between psychosocial factors and health behavior change in cancer survivors: an integrative review. Ann Behav Med. 2007;34(2):115-134. https://doi.org/10.1007/BF02872667
Lambert LK, Balneaves LG, Howard AF, Gotay CC. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review. Breast Canc Res Treat. 2018;167(3):615-633. https://doi.org/10.1007/s10549-017-4561-5
Chirico A, Lucidi F, Merluzzi T, et al. A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life. Oncotarget. 2017;8(22):36800-36811. https://doi.org/10.18632/oncotarget.15758
Philip EJ, Merluzzi TV, Zhang Z, Heitzmann CA. Depression and cancer survivorship: importance of coping self-efficacy in post-treatment survivors. Psycho-Oncology. 2013;22(5):987-994. https://doi.org/10.1002/pon.3088
Heitzmann CA, Merluzzi TV, Jean-Pierre P, Roscoe JA, Kirsh KL, Passik SD. Assessing self-efficacy for coping with cancer: development and psychometric analysis of the brief version of the cancer behavior inventory (CBI-B). Psycho-Oncology. 2011;20(3):302-312. https://doi.org/10.1002/pon.1735
Raque-Bogdan TL, Lent RW, Lamphere B. Test of a social cognitive model of well-being among breast cancer survivors. J Health Psychol. 2019;24(5):661-670. https://doi.org/10.1177/1359105316681431
Giesler JM, Weis J. Patient competence in the context of cancer: its dimensions and their relationships with coping, coping self-efficacy, fear of progression, and depression. Support Care Canc. 2020;29: 2133-2143. https://doi.org/10.1007/s00520-020-05699-0
Henselmans I, Fleer J, de Vries J, Baas PC, Sanderman R, Ranchor AV. The adaptive effect of personal control when facing breast cancer: cognitive and behavioural mediators. Psychol Health. 2010;25(9):1023-1040. https://doi.org/10.1080/08870440902935921
McGinty HL, Small BJ, Laronga C, Jacobsen PB. Predictors and patterns of fear of cancer recurrence in breast cancer survivors. Health Psychol. 2016;35(1):1-9. https://doi.org/10.1037/hea0000238
Brandão T, Schulz MS, Matos PM. Psychological adjustment after breast cancer: a systematic review of longitudinal studies. Psycho-Oncology. 2017;26(7):917-926. https://doi.org/10.1002/pon.4230
Kant J, Czisch A, Schott S, Siewerdt-Werner D, Birkenfeld F, Keller M. Identifying and predicting distinct distress trajectories following a breast cancer diagnosis - from treatment into early survival. J Psychosomatic Res. 2018;115:6-13. https://doi.org/10.1016/j.jpsychores.2018.09.012
Adams RN, Mosher CE, Cohee AA, et al. Avoidant coping and self-efficacy mediate relationships between perceived social constraints and symptoms among long-term breast cancer survivors. Psycho-Oncology. 2017;26(7):982-990. https://doi.org/10.1002/pon.4119
Ahmad S, Fergus K, Shatokhina K, Gardner S. The closer ‘We’ are, the stronger ‘I’ am: the impact of couple identity on cancer coping self-efficacy. J Behav Med. 2017;40(3):403-413. https://doi.org/10.1007/s10865-016-9803-1
Nairn RC, Merluzzi TV. Enhancing coping skills for persons with cancer utilizing mastery enhancement: a pilot randomized clinical trial. J Behav Med. 2019;42(3):423-439. https://doi.org/10.1007/s10865-018-0004-y
Schwarzer R. Self-efficacy in the adoption and maintenance of health behaviors: Theoretical approaches and a new model. In: Schwarzer R, ed. Self-Efficacy: Thought control on action. Washington, DC: Hemisphere; 1992:217-243.
Locke EA, Latham GP. A Theory of Goal Setting and Task Performance. Englewood Cliffs, NJ: Prentice Hall; 1990.
Bandura A. Regulation of cognitive processes through perceived self-efficacy. Dev Psychol. 1989;25(5):729-735. https://doi.org/10.1037/0012-1649.25.5.729
Lightsey OR, Burke M, Ervin A, Henderson D, Yee C. Generalized self-efficacy, self-esteem, and negative affect. Can J Behav Sci/Revue Can des Sci du comportement. 2006;38(1):72-80. https://doi.org/10.1037/h0087272
Schüz B, Wurm S, Warner LM, Ziegelmann JP. Self-efficacy and multiple illness representations in older adults: a multilevel approach. Psychol Health. 2012;27(1):13-29. https://doi.org/10.1080/08870446.2010.541908
Beckham JC, Burker EJ, Burker EJ, Feldman ME, Costakis MJ. Self-Efficacy and adjustment in cancer patients: a preliminary report. Behav Med. 1997;23(3):138-142. https://doi.org/10.1080/08964289709596370
Hagger MS, Koch S, Chatzisarantis NLD, Orbell S. The common sense model of self-regulation: meta-analysis and test of a process model. Psychol Bull. 2017;143(11):1117-1154. https://doi.org/10.1037/bul0000118
Aljasem LI, Peyrot M, Wissow L, Rubin RR. The impact of barriers and self-efficacy on self-care behaviors in type 2 diabetes. Diabetes Educat. 2001;27(3):393-404. https://doi.org/10.1177/014572170102700309
Salovey P, Rothman AJ, Detweiler JB, Steward WT. Emotional states and physical health. Am Psychol. 2000;55(1):110-121. https://doi.org/10.1037/0003-066X.55.1.110
Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosomatic Res. 2006;60(6):631-637. https://doi.org/10.1016/j.jpsychores.2005.10.020
Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Personality Soc Psychol. 1988;54(6):1063-1070. https://doi.org/10.1037/0022-3514.54.6.1063
Watson M, Law MG, Santos Md, Greer S, Baruch J, Bliss J. The mini-MAC. J Psychosoc Oncol. 1994;12(3):33-46. https://doi.org/10.1300/J077V12N03_03
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI J Natl Cancer Inst. 1993;85(5):365-376. https://doi.org/10.1093/jnci/85.5.365
Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis. A Regression-Based Approach. New York, NY: Guilford; 2013.
Merluzzi TV, Pustejovsky JE, Philip EJ, Sohl SJ, Berendsen M, Salsman JM. Interventions to enhance self-efficacy in cancer patients: a meta-analysis of randomized controlled trials. Psycho-Oncology. 2019;28(9):1781-1790. https://doi.org/10.1002/pon.5148
Fioretti C, Mazzocco K, Pravettoni G. Psychological support in breast cancer patients: a personalized approach. In: Veronesi U, Goldhirsch A, Veronesi P, Gentilini O, Leonardi M, eds. Breast cancer. Springer International Publishing; 2017:841-847.
Cutica I, Vie GM, Pravettoni G. Personalised medicine: the cognitive side of patients. Eur J Intern Med. 2014;25(8):685-688. https://doi.org/10.1016/j.ejim.2014.07.002

Auteurs

Evangelos C Karademas (EC)

Department of Psychology, University of Crete, and Foundation for Research and Technology-Hellas, Greece.

Panagiotis Simos (P)

Medical School, University of Crete, and Foundation for Research and Technology-Hellas, Greece.

Ruth Pat-Horenczyk (R)

School of Social Work and Social Welfare, Hebrew University of Jerusalem, Israel.

Ilan Roziner (I)

Department of Communication Disorders, Sackler Faculty of Medicine, University of Tel Aviv, Israel.

Ketti Mazzocco (K)

Department of Oncology and Hemato-oncology, University of Milan, & Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, Milan, Italy.

Berta Sousa (B)

Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Champalimaud Research, Lisboa, Portugal.

Albino J Oliveira-Maia (AJ)

Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, and NOVA Medical School, NMS, Universidade Nova de Lisboa, Lisboa, Portugal.

Georgios Stamatakos (G)

School of Electrical and Computer Engineering, Institute of Communication and Computer Systems, National Technical University of Athens, Athens, Greece.

Fatima Cardoso (F)

Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisboa, Portugal.

Diana Frasquilho (D)

Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Champalimaud Foundation, Lisboa, Portugal.

Eleni Kolokotroni (E)

School of Electrical and Computer Engineering, Institute of Communication and Computer Systems, National Technical University of Athens, Athens, Greece.

Chiara Marzorati (C)

Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, Milan, Italy.

Johanna Mattson (J)

Helsinki University Hospital Comprehensive Cancer Center, and Helsinki University, Helsinki, Finland.

Greta Pettini (G)

Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, Milan, Italy.

Paula Poikonen-Saksela (P)

Helsinki University Hospital Comprehensive Cancer Center, and Helsinki University, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH